Cart
sales@molnova.com
LY900009
CAS No. 209984-68-9
LY900009( —— )
Catalog No. M23950 CAS No. 209984-68-9
LY900009 is a small molecule inhibitor of Notch signalling via selective inhibition of the γ-secretase protein.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 89 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 207 | In Stock |
|
| 50MG | 300 | In Stock |
|
| 100MG | 434 | In Stock |
|
| 200MG | 609 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY900009
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY900009 is a small molecule inhibitor of Notch signalling via selective inhibition of the γ-secretase protein.
-
DescriptionLY900009 is a small molecule inhibitor of Notch signalling via selective inhibition of the γ-secretase protein.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGamma-secretase
-
Recptorγ secretase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number209984-68-9
-
Formula Weight409.49
-
Molecular FormulaC23H27N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)[C@H](C(C)C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer[J]. European Journal of Cancer, 2016, 56.
molnova catalog
related products
-
Demcizumab
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody and a potent Notch pathway inhibitor, demonstrating efficacy in various cancer models both as a monotherapy and in conjunction with chemotherapy agents.
-
Monomethyl auristati...
Monomethyl auristatin E (MMAE), an antimitotic agent, inhibits cell division by blocking the polymerization of tubulin and also has inhibition of antibody-drug conjugates (ADCs) activity.
-
Fosciclopirox
Fosciclopirox, the phosphoryloxymethyl ester of CPX (Ciclopirox Prodrug, CPX-POM), selectively delivers the active metabolite, CPX, to the entire urinary tract following parenteral administration.
